Clinical Trial Update: Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of apatinib mesylate and pemetrexed in patients with pretreated advanced non-squamous non-small cell lung cancer. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib Mesylate (apatinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Wuling Ou | Conditions: Nonsmall Cell Lung Cancer | Phase 2 | Status: UNKNOWN